Month: February 2021

ATHENS, Greece, Feb. 25, 2021 (GLOBE NEWSWIRE) — STEALTHGAS INC. (NASDAQ: GASS), a ship-owning company primarily serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today its unaudited financial and operating results for the fourth quarter and twelve months ended December 31, 2020.OPERATIONAL AND FINANCIAL HIGHLIGHTS1Fleet utilization of 98.5% with 60 days of technical off hire mainly as a result of two drydockings completed within Q4 2020.Fleet operational utilization of 93.6% mainly due to a number of our ships having a presence in the spot market – equivalent to 28.7% of calendar days.Fleet calendar days, down by 2% quarter over quarter to 3,873 – the decrease attributable mostly to our strategic fleet contraction.About 50% of fleet days secured on period charters for the remainder...

This follow-on order brings 575 Blink Chargers to the Caribbean, Central and South AmericaMiami Beach, FL, Feb. 25, 2021 (GLOBE NEWSWIRE) — Blink Charging Co. (Nasdaq: BLNK, BLNKW) (“Blink” or the “Company”), a leading owner, operator, and provider of electric vehicle (EV) charging equipment and services, today announced that it had received a follow-on order from the InterEnergy Group for 150 fast-charging stations, including 100 Blink IQ 200 units and 50 DCFC units, to be deployed across the Dominican Republic.Valued at approximately $1.0 million, this order marks the fourth-order Blink has received from InterEnergy and the third agreement between the two companies to deploy EV equipment in the Dominican Republic. Blink also recently announced an initial order from InterEnergy for the deployment of charging stations in Panama...

Los Angeles, CA, Feb. 25, 2021 (GLOBE NEWSWIRE) — Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer‎, announced today that the CEO of the Company, Cameron Chell, will speak on the Sustainability/Rethinking Impact 2021 panel hosted by Canaccord Genuity.The virtual event takes place on March 4, 2021 at 10AM PST/1PM EST. Cameron Chell will join a panel to discuss: Rethinking Autonomy and the Drone Economy moderated by Ken Herbert, Managing Director, Canaccord Genuity Equity Research. The panel will focus on drones and their disruptive potential in the package delivery and logistics markets,“I am honored to be part of Canaccord’s inaugural Global Sustainability Event,” said Cameron Chell, CEO of Draganfly. “Canaccord has put together...

Company progresses from LOI to MIPA3 to acquire cultivation and production licenses and to begin cultivation on proprietary landLas Vegas, NV, Feb. 25, 2021 (GLOBE NEWSWIRE) — MJ Holdings, Inc. (OTC Pink: MJNE) a diversified holding company, which through its subsidiaries, provides services to the regulated cannabis industry inclusive of cultivation and production management, infrastructure development and sales is pleased to inform shareholders that it has progressed from a Letter of Intent (LOI) to a Membership Interest Purchase Agreement (MIPA3) to purchase two cultivation licenses (medical and recreational) and two production licenses (medical and recreational) and transfer the appropriate licenses to proprietary land.The MIPA3 with MJ Distributing, Inc. and affiliates (not related to MJ Holdings, Inc) provides for a closing...

A newly published review article in the journal CELLS highlights the role LTB4 plays in the induction of vascular endothelial growth factor (VEGF) damage and retinal inflammation in the eye.Elevated VEGF is associated with choroidal neovascularisation (CNV), the cause of wet AMD. Recent data from a laser-induced CNV model suggests one dose of long-acting PASylated nomacopan (PAS-nomacopan) reduced neo-vascularisation by the same amount as Eyelea®, a U.S. Food and Drug Administration (FDA)-approved treatment for AMD.The combined impact of bifunctional nomacopan, which inhibits LTB4, and thereby VEGF production, and also inhibits complement C5, may provide a unique modality for treatment of a number of serious eye diseases, including uveitis and both dry and wet AMD.NEW YORK and LONDON, Feb. 25, 2021 (GLOBE NEWSWIRE) — Akari Therapeutics,...

OMER, Israel, Feb. 25, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the pricing of an underwritten public offering of 3,258,438 American Depositary Shares (the “ADSs”). Each ADS is being sold to the public at a price per ADS of $2.60. The gross proceeds to the Company from this offering are expected to be approximately $8.5 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. The offering is expected to close on or about March 1, 2021, subject to customary closing conditions.The Company intends to use the net proceeds from this offering for working capital and general corporate purposes.In addition, the Company has granted the underwriter...

Meddelelse nr. 3 – 2021til Nasdaq Copenhagen   2021.02.25Årsrapport 2020 – rekordresultat og indstilling om øget udbytteFor Brødrene A & O Johansen A/S og koncernen (AO) har året 2020 været præget af en højere salgsvækst end forventet.Størstedelen af 2020 har været påvirket af COVID-19. I perioder med delvis nedlukning af mange dele af samfundet har kunderne efterspurgt fleksibilitet ved valg af salgsplatforme og handelsform. AO har som omnichannel-virksomhed kunnet tilbyde dette.Omsætningen i 2020 udgjorde 4.098,3 mio. kr., svarende til en salgsvækst på 14,4 %. Salget fordeltes med 3.502,4 mio. kr. fra det professionelle marked (B2B) og 595,9 mio. kr. fra privatmarkedet (B2C). Væksten i det professionelle marked udgjorde 11,6 %, mens væksten i det private marked udgjorde 34,4 %. For så vidt angår væksten i det private marked, kan...